RU2012137061A - PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND THEIR APPLICATION IN THE TREATMENT OF CEREBROVASCULAR DISORDERS - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND THEIR APPLICATION IN THE TREATMENT OF CEREBROVASCULAR DISORDERS Download PDF

Info

Publication number
RU2012137061A
RU2012137061A RU2012137061/15A RU2012137061A RU2012137061A RU 2012137061 A RU2012137061 A RU 2012137061A RU 2012137061/15 A RU2012137061/15 A RU 2012137061/15A RU 2012137061 A RU2012137061 A RU 2012137061A RU 2012137061 A RU2012137061 A RU 2012137061A
Authority
RU
Russia
Prior art keywords
cerebrovascular disorders
amlodipine
nicotinate
treatment
pharmaceutical composition
Prior art date
Application number
RU2012137061/15A
Other languages
Russian (ru)
Other versions
RU2516922C2 (en
Inventor
Рубен Симонович Мирзоян
Тамара Сергеевна Ганьшина
Original Assignee
Общество с ограниченной ответственностью "Консорциум - ПИК"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Консорциум - ПИК" filed Critical Общество с ограниченной ответственностью "Консорциум - ПИК"
Priority to RU2012137061/15A priority Critical patent/RU2516922C2/en
Publication of RU2012137061A publication Critical patent/RU2012137061A/en
Application granted granted Critical
Publication of RU2516922C2 publication Critical patent/RU2516922C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Применение S-амлодипина никотината в лечении цереброваскулярных нарушений.2. Применение по п.1, где цереброваскулярные нарушения выбраны из группы: геморрагический инсульт, ишемический инсульт, в том числе глобальная преходящая ишемия.3. Фармацевтическая композиция для лечения цереброваскулярных нарушений, содержащая в качестве активного компонента S-амлодипина никотинат и фармацевтически приемлемые наполнители, отличающаяся тем, что содержит в качестве активного компонента S-амлодипина никотинат в эффективном количестве от 0,1 мг-50 мг на дозу.4. Фармацевтическая композиция по п.3, отличающаяся тем, что представляет собой таблетку либо твердую желатиновую капсулу, либо раствор для инъекций или инфузий.1. The use of S-amlodipine nicotinate in the treatment of cerebrovascular disorders. 2. The use according to claim 1, where the cerebrovascular disorders are selected from the group: hemorrhagic stroke, ischemic stroke, including global transient ischemia. A pharmaceutical composition for treating cerebrovascular disorders, containing nicotinate and pharmaceutically acceptable excipients as the active ingredient of S-amlodipine, characterized in that it contains nicotinate in an effective amount of 0.1 mg-50 mg per dose as the active ingredient of S-amlodipine. The pharmaceutical composition according to claim 3, characterized in that it is a tablet or a hard gelatin capsule, or a solution for injection or infusion.

Claims (4)

1. Применение S-амлодипина никотината в лечении цереброваскулярных нарушений.1. The use of S-amlodipine nicotinate in the treatment of cerebrovascular disorders. 2. Применение по п.1, где цереброваскулярные нарушения выбраны из группы: геморрагический инсульт, ишемический инсульт, в том числе глобальная преходящая ишемия.2. The use according to claim 1, where cerebrovascular disorders are selected from the group: hemorrhagic stroke, ischemic stroke, including global transient ischemia. 3. Фармацевтическая композиция для лечения цереброваскулярных нарушений, содержащая в качестве активного компонента S-амлодипина никотинат и фармацевтически приемлемые наполнители, отличающаяся тем, что содержит в качестве активного компонента S-амлодипина никотинат в эффективном количестве от 0,1 мг-50 мг на дозу.3. A pharmaceutical composition for treating cerebrovascular disorders, comprising nicotinate and pharmaceutically acceptable excipients as the active ingredient of S-amlodipine, characterized in that it contains nicotinate in an effective amount of 0.1 mg-50 mg per dose as the active ingredient of S-amlodipine. 4. Фармацевтическая композиция по п.3, отличающаяся тем, что представляет собой таблетку либо твердую желатиновую капсулу, либо раствор для инъекций или инфузий. 4. The pharmaceutical composition according to claim 3, characterized in that it is a tablet or a hard gelatin capsule, or a solution for injection or infusion.
RU2012137061/15A 2012-08-30 2012-08-30 Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders RU2516922C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012137061/15A RU2516922C2 (en) 2012-08-30 2012-08-30 Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012137061/15A RU2516922C2 (en) 2012-08-30 2012-08-30 Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders

Publications (2)

Publication Number Publication Date
RU2012137061A true RU2012137061A (en) 2014-03-10
RU2516922C2 RU2516922C2 (en) 2014-05-20

Family

ID=50191390

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012137061/15A RU2516922C2 (en) 2012-08-30 2012-08-30 Pharmaceutical compositions containing s-amlodipine nicotinate and using them in treating cerebrovascular disorders

Country Status (1)

Country Link
RU (1) RU2516922C2 (en)

Also Published As

Publication number Publication date
RU2516922C2 (en) 2014-05-20

Similar Documents

Publication Publication Date Title
UA109991C2 (en) CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
EA201592256A1 (en) DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
EA201690223A1 (en) FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
EA201690287A1 (en) 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY
EA201492290A1 (en) COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES
JP2015517488A5 (en)
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
EA201592255A1 (en) DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE
RU2018135973A (en) PHARMACEUTICAL COMBINATION CONTAINING METROFORMIN AND DYHYDROQUERCENINE, AND ITS APPLICATION FOR TREATING CANCER
EA201400067A1 (en) NEW THERAPEUTIC COMPOSITION CONTAINING APOMORPHIN AS AN ACTIVE INGREDIENT
RU2019139886A (en) THERAPEUTIC AGAINST DYSFUNCTION OF MEIBOMIUM GLANDS
RU2014129508A (en) NEW COMBINATION
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
EA201500513A1 (en) SOMICRONIZATION PRODUCT, INCLUDING ULETRIDAL ACETATE
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
PH12019502510A1 (en) Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
EA201490573A1 (en) CONTAINING BENZOTHIAZOLONE
EA201591653A1 (en) COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL
MX2017005163A (en) Onapristone extended-release compositions and methods.
EA201200754A1 (en) TRADITIONAL CHINESE DRUG, CONTAINING DAN-SHEN EXTRACTS (DANSHEN) AND SAN-KI (SANQI), AND ITS APPLICATION
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.